Clearside Biomedical, Inc.CLSDNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank17
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P17
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -0.52% |
| 2023 | 0.84% |
| 2022 | 0.90% |
| 2021 | 8.45% |
| 2020 | -36.05% |
| 2019 | 14.54% |
| 2018 | 51.38% |
| 2017 | 54.88% |
| 2016 | -4.45% |
| 2015 | 109.36% |